KORU Medical Systems Appoints Adam Kalbermatten President, CEO, Succeeding Linda Tharby

KORU Medical Systems, Inc. (NASDAQ:KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on the development, manufacturing, and commercialization of innovative and patient-centric large volume subcutaneous infusion solutions, today announced that following five years of service to the Company, Linda Tharby, President and Chief Executive Officer, will retire effective June 30, 2026. The Board of Directors has appointed Adam Kalbermatten, currently Chief Commercial Officer, as President and Chief Executive Officer, effective March 15, and July 1, 2026, respectively.

The result of thoughtful, long-range succession planning, this transition reflects the Board's confidence in Mr. Kalbermatten's experience and capabilities, the Company's strategic direction, and the depth of KORU's leadership team. Ms. Tharby will remain on the Board of Directors and serve in an advisory capacity through the end of 2026 to support this leadership succession plan.